SHOULDER INNOVATIONS, INC. (SI) 8-K Current Report: March 2, 2026
Filed: March 2, 2026
Health Care
Surgical & Medical Instruments & ApparatusSHOULDER INNOVATIONS, INC. (SI) 8-K current report filed with SEC EDGAR on March 2, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items2 items
- Item 5.02: Departure/Election of Directors or Officers
- Item 7.01: Regulation FD Disclosure
SHOULDER INNOVATIONS, INC. 8-K Mar 2, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • Geoff Pardo resigned Feb 26, 2026 from Board, Compensation Committee, and Chair of Nominating & Corporate Governance Committee — no disagreement cited
- • Andrew Hykes (age 53) appointed Class I director and Compensation Committee member, filling Pardo's vacancy effective immediately
- • Hykes brings deep medtech operational experience: CEO/President of Inari Medical (2023–2025) and prior COO/CCO roles there; now CEO of Okami Medical since Oct 2025
- • Earlier career includes VP roles at Medtronic and neurovascular startup Sequent Medical (acquired by Terumo 2016) — strong commercial and regulatory background
- • Hykes deemed independent by Board, compensated under existing Non-Employee Director Compensation Program; no related-party transaction concerns flagged
Item 7.01 · Regulation FD Disclosure
- • Press release issued March 2, 2026 disclosing material company developments — full details in Exhibit 99.1
- • Reg FD filing ensures simultaneous public disclosure, signaling information deemed market-moving by management
Other SHOULDER INNOVATIONS, INC. 8-K Filings
Get deeper insights on SHOULDER INNOVATIONS, INC.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.